Protein and low molecular mass thiols as targets and inhibitors of glycation reactions

Chemical Research in Toxicology

Volumn 19, Issue 12, 2006, Pages 1668-1676

  Zeng, Jingmin ^a   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ACETYLCYSTEINE; ALKYL GROUP; AMINE; AMINOGUANIDINE; ARGININE; CARBOCISTEINE; CARBONYL DERIVATIVE; CREATINE KINASE; CYSTEINE; GLYOXAL; HISTIDINE; HISTONE H1; LYSINE; LYSOZYME; NITROGEN; THIOL DERIVATIVE;

AGING; AMINO TERMINAL SEQUENCE; ARTICLE; ATHEROSCLEROSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENZYME INACTIVATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; PROTEIN TARGETING;

AMINO ACIDS; CREATINE KINASE; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; GLYOXAL; MOLECULAR WEIGHT; MURAMIDASE; PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFHYDRYL COMPOUNDS;

EID: 33845780096     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0602158     Document Type: Article

References (54)

1. Baynes, J. W., and Thorpe, S. R. (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radical Biol. Med. 28, 1708-1716.
2. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
3. Thornalley, P. J. (2005) Dicarbonyl intermediates in the Maillard reaction. Ann. N. Y. Acad. Sci. 1043, 111-117.
4. Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., and Maeda, K. (1999) Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 256, 89-93.
5. Lapolla, A., Flamini, R., Dalla, Vedova, A., Senesi, A., Reitano, R., Fedele, D., Basso, E., Seraglia, R., and Traldi, P. (2003) Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 41, 1166-1173.
6. Hazen, S. L., Hsu, F. F., d'Avignon, A., and Heinecke, J. W. (1998) Human neutrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: A pathway for aldehyde generation at sites of inflammation. Biochemistry 37, 6864-6873.
7. Thornalley, P. J., Langborg, A., and Minhas, H. S. (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344, 109-116.
8. Miyata, T., Kurokawa, K., van Ypersele, De, and Strihou, C. (2000) Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 11, 1744-1752.
9. Baynes, J. W. (2003) Chemical modification of proteins by lipids in diabetes. Clin. Chem. Lab. Med. 41, 1159-1165.
10. Lo, T. W., Westwood, M. E., McLellan, A. C., Selwood, T., and Thornalley, P. J. (1994) Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269, 32299-32305.
11. Howard, E. W., Benton, R., Ahern-Moore, J., and Tomasek, J. J. (1996) Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation. Exp. Cell Res. 228, 132-137.
12. Bulteau, A. L., Verbeke, P., Petropoulos, I., Chaffotte, A. F., and Friguet, B. (2001) Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. J. Biol. Chem. 276, 45662-45668.
13. Zeng, J., Dunlop, R. A., Rodgers, K. J., and Davies, M. J. (2006) Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem. J. 398, 197-206.
14. Aronson, D. (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 21, 3-12.
15. Morgan, P. E., Dean, R. T., and Davies, M. J. (2002) Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch. Biochem. Biophys. 403, 259-269.
16. Zeng, J., and Davies, M. J. (2005) Evidence for the formation of adducts and 5-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem. Res. Toxicol. 18, 1232-1241.
17. Rahbar, S., and Figarola, J. L. (2003) Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 63-79.
18. Wondrak, G. T., Cervantes-Laurean, D., Roberts, M. J., Qasem, J. G., Kim, M., Jacobson, E. L., and Jacobson, M. K. (2002) Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 63, 361-373.
19. Yao, Q. Z., Hou, L. X., Zhou, H. M., and Zou, C. G. (1982) Conformational changes of creatine kinase during guanidine denaturation. Sci. Sin. [B] 25, 1186-1193.
20. Uchida, K., and Stadtman, E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 268, 6388-6393.
21. Ishii, T., Tatsuda, E., Kumazawa, S., Nakayama, T., and Uchida, K. (2003) Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 42, 3474-3480.
22. Wang, P. F., McLeish, M. J., Kneen, M. M., Lee, G., and Kenyon, G. L. (2001) An unusually low pK(a) for Cys282 in the active site of human muscle creatine kinase. Biochemistry 40, 11698-11705.
23. Kliegman, J. M., and Barnes, R. K. (1970) Glyoxal derivatives. 3. Reaction of glyoxal with some secondary amines. J. Heterocycl. Chem. 7, 1153-1155.
24. Popovich, B. K., Boheler, K. R., and Dillmann, W. H. (1989) Diabetes decreases creatine kinase enzyme activity and mRNA level in the rat heart. Am. J. Physiol. 257, E573-577.
25. Awaji, Y., Hashimoto, H., Matsui, Y., Kawaguchi, K., Okumura, K., Ito, T., and Satake, T. (1990) Isoenzyme profiles of creatine kinase, lactate dehydrogenase, and aspartate aminotransferase in the diabetic heart: Comparison with hereditary and catecholamine cardiomyopathies. Cardiovasc. Res. 24, 547-554.
26. Mekhfi, H., Veksler, V., Mateo, P., Maupoil, V., Rochette, L., and Ventura-Clapier, R. (1996) Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circ. Res. 78, 1016-1027.
27. Koufen, P., and Stark, G. (2000) Free radical induced inactivation of creatine kinase: Sites of interaction, protection, and recovery. Biochim. Biophys. Acta 1501, 44-50.
28. Grossman, S. H., Le, Jeune, B., and Mixon, D. (1983) A comparison of native and covalently crosslinked creatine kinases: Denaturation and reassembly. Arch. Biochem. Biophys. 224, 449-455.
29. Horakova, E., Ondrejickova, O., Vajdova, M., Korytar, P., Durackova, Z., and Schaur, R. J. (2002) Mechanisms of iron-induced oxidative modifications of creatine kinase in rat brain in vitro. Possible involvement of HNE. Gen. Physiol. Biophys. 21, 327-336.
30. Glomb, M. A., and Monnier, V. M. (1995) Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270, 10017-10026.
31. Glomb, M. A., and Pfahler, C. (2001) Amides are novel protein modifications formed by physiological sugars. J. Biol. Chem. 276, 41638-41647.
32. Okuda, K., Urabe, I., Yamada, Y., and Okada, H. (1991) Reaction of glutaraldehyde with amino and thiol compounds. J. Ferment. Bioeng. 71, 100-105.
33. Furuhata, A., Nakamura, M., Osawa, T., and Uchida, K. (2002) Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols. J. Biol. Chem. 277, 27919-27926.
34. Zhang, W. H., Liu, J., Xu, G., Yuan, Q., and Sayre, L. M. (2003) Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 16, 512-523.
35. Nagaraj, R. H., Portero-Otin, M., and Monnier, V. M. (1996) Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes. Arch. Biochem. Biophys. 325, 152-158.
36. Oya, T., Kumon, H., Kobayashi, H., Akiba, M., Hosokawa, T., Kakimoto, N., Nakamura, K., Morimitsu, Y., and Osawa, T. (1998) A novel biomarker for hyperglycemia, MRX isolated from hydrolysate of glycated proteins. Biochem. Biophys. Res. Commun. 246, 267-271.
37. Laland, P., Alvsaker, J. O., Haugli, F., Dedichen, J., Laland, S., and Thorsdalen, N. (1966) Presence in lipoproteins from human serum of a crystalline blue fluorescent substance of unknown structure isolated from bovine liver. Nature 210, 917-919.
38. Thorpe, S. R., and Baynes, J. W. (2003) Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids 25, 275-281.
39. Alt, N., Carson, J. A., Alderson, N. L., Wang, Y., Nagai, R., Henle, T., Thorpe, S. R., and Baynes, J. W. (2004) Chemical modification of muscle protein in diabetes. Arch. Biochem. Biophys. 425, 200-206.
40. Ubuka, T., Kodama, H., and Mizuhara, S. (1967) Isolation of S-(carboxymethyl)cysteine from urine. Biochim. Biophys. Acta 141, 266-269.
41. Deshmukh, K., and Nimni, M. E. (1969) A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process. J. Biol. Chem. 244, 1787-1795.
42. Chen, C., and Loo, G. (1995) Inhibition of lecithin:cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes. J. Biochem. Toxicol. 10, 121-128.
43. McCall, M. R., Tang, J. Y., Bielicki, J. K., and Forte, T. M. (1995) Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arterioscler. Thromb. Vasc. Biol. 15, 1599-1606.
44. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., and Cerami, A. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1632.
45. Lehman, T. D., and Ortwerth, B. J. (2001) Inhibitors of advanced glycation end product-associated protein cross-linking. Biochim. Biophys. Acta 1535, 110-119.
46. Ikeda, K., Nagai, R., Sakamoto, T., Sano, H., Araki, T., Sakata, N., Nakayama, H., Yoshida, M., Ueda, S., and Horiuchi, S. (1998) Immunochemical approaches to AGE-structures: Characterization of anti-AGE antibodies. J. Immunol. Meth. 215, 95-104.
47. Sakai, A., Nakayama, M., Numata, M., Takesawa, S., and Nakamoto, M. (2001) Sodium sulfite and N-acetylcysteine: New additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products. Adv. Perit. Dial. 17, 66-70.
48. Burcham, P. C., Fontaine, F. R., Kaminskas, L. M., Petersen, D. R., and Pyke, S. M. (2004) Protein adduct-trapping by hydrazinophthalazine drugs: Mechanisms of cytoprotection against acrolein-mediated toxicity. Mol. Pharmacol. 65, 655-664.
49. Nangaku, M., Miyata, T., Sada, T., Mizuno, M., Inagi, R., Ueda, Y., Ishikawa, N., Yuzawa, H., Koike, H., van Ypersele, de Strihou, C., and Kurokawa, K. (2003) Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J. Am. Soc. Nephrol. 14, 1212-1222.
50. Miyata, T., Yamamoto, M., and Izuhara, Y. (2005) From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy. Ann. N. Y. Acad. Sci. 1043, 740-749.
51. Coughlan, M. T., Cooper, M. E., and Forbes, J. M. (2005) Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes? Ann. N. Y. Acad. Sci. 1043, 750-758.
52. Beard, K. M., Shangari, N., Wu, B., and O'Brien, P. J. (2003) Metabolism, not autoxidation, plays a role in alpha-oxoaldehyde- and reducing sugar-induced erythrocyte GSH depletion: Relevance for diabetes mellitus. Mol. Cell. Biochem. 252, 331-338.
53. Pasaoglu, H., Sancak, B., and Bukan, N. (2004) Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J. Exp. Med. 203, 211-218.
54. Thornalley, P. J., McLellan, A. C., Lo, T. W., Benn, J., and Sonksen, P. H. (1996) Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin. Sci. (Lond.) 91, 575-582.